Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy

BACKGROUND: The systemic immune-inflammation index (SII) has recently emerged as a predictor of survival in non-small cell lung cancer patients. There is also tight correlation between radiotherapy and immune status, and brain metastases (BM) radiotherapy is an important treatment in patients with B...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Tan, Xiaojing, Deng, Guangchuan, Fu, Shuai, Li, Jianbin, Li, Zhenxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895866/
https://www.ncbi.nlm.nih.gov/pubmed/35241046
http://dx.doi.org/10.1186/s12890-022-01866-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895866/
https://www.ncbi.nlm.nih.gov/pubmed/35241046
http://dx.doi.org/10.1186/s12890-022-01866-7

Ejemplares similares